MR screening moves into CT void

Article

Some walk-in CT clinics in the U.S. may be closing their doors, but the concept of consumer-led preventive imaging is far from dead, particularly in Asia. Interest there is switching to MR as a screening tool to reassure "the worried well" and reveal dormant disease.

During the last four years, for example, more than 4000 people have undergone a whole-body MR exam at the Imaging Center at Veterans General Hospital (VGH) in Taipei, Taiwan. Self-referrals account for most whole-body MR exams, which are available to anyone who can pay ($US1000 for complete tumor survey and another $US1000 for neurovascular or cardiac assessment).

Charles H. Cheng, Ph.D., an attending physician in the VGH radiology department, acknowledges that the screening program will attract criticism, but he insists that the whole-body scans will do more good than harm.

"Many people from countries that have comprehensive primary healthcare systems misunderstand what we are doing. They do not realize that what works in Asia is sometimes different from what works elsewhere," Cheng said at the 2004 Asian and Oceanian Congress of Radiology.

Recent Videos
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Related Content
© 2025 MJH Life Sciences

All rights reserved.